Streptococcal pyrogenic exotoxin B enhances tissue damage initiated by other Streptococcus pyogenes products

J Infect Dis. 2001 Sep 15;184(6):723-31. doi: 10.1086/323083. Epub 2001 Aug 10.

Abstract

This study compared the pathology and infection pattern of streptococcal pyrogenic exotoxin B-positive (SpeB(+)) and SpeB-negative (SpeB(-)) isogenic variants of an M1 isolate of Streptococcus pyogenes in a mouse skin air sac model. SpeB(+) strains resulted in severe local tissue damage that extended from the epidermis through the subcutaneous layers, whereas isogenic SpeB(-) variants had reduced gross pathology. At the histologic level, differences in necrosis and host responses to each variant were apparent. Injection of purified SpeB alone into a skin air sac failed to induce any significant tissue damage; however, coinjection of the enzyme with either the wild-type or the speB mutant resulted in increased and accelerated tissue necrosis. Surprisingly, coinjection of the enzyme with the spleen-recovered SpeB(-) variant failed to induce a lesion.

Publication types

  • Comparative Study
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Bacterial Proteins*
  • Blotting, Northern
  • Epidermis / drug effects
  • Epidermis / pathology
  • Exotoxins / genetics
  • Exotoxins / isolation & purification
  • Exotoxins / toxicity*
  • Gene Expression Regulation, Bacterial
  • Membrane Proteins*
  • Mice
  • Muscle, Skeletal / drug effects
  • Muscle, Skeletal / pathology
  • Phenotype
  • Skin / drug effects
  • Skin / microbiology
  • Skin / pathology*
  • Streptococcal Infections / pathology*
  • Streptococcus pyogenes / genetics*
  • Time Factors

Substances

  • Bacterial Proteins
  • Exotoxins
  • Membrane Proteins
  • SpeA protein, Streptococcus pyogenes
  • erythrogenic toxin